A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

Recruiting

Phase 2

Radiation & ChemotherapyA Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

Sponsor:

Memorial Sloan Kettering Cancer Center

Code:

NCT05491512

Conditions

HPV

Throat Cancer

Oropharyngeal Carcinoma

Oropharyngeal Cancer

Human Papilloma Virus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

18 F-FMISO PET/CT

Radiation

Cisplatin

Carboplatin

5-fluorouracil

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-01. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2025-08-28.